BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20367506)

  • 1. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension.
    Anumba DO; Lincoln K; Robson SC
    Hypertens Pregnancy; 2010 Jan; 29(2):163-79. PubMed ID: 20367506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
    Hawkins TL; Roberts JM; Mangos GJ; Davis GK; Roberts LM; Brown MA
    BJOG; 2012 Mar; 119(4):484-92. PubMed ID: 22251368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum uric acid in women with gestational hypertension.
    Bellomo G; Venanzi S; Saronio P; Verdura C; Narducci PL
    Hypertension; 2011 Oct; 58(4):704-8. PubMed ID: 21876075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women?
    Schmella MJ; Clifton RG; Althouse AD; Roberts JM
    Reprod Sci; 2015 Oct; 22(10):1212-9. PubMed ID: 25717062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.
    Wu Y; Xiong X; Fraser WD; Luo ZC
    Am J Hypertens; 2012 Jun; 25(6):711-7. PubMed ID: 22378034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension?
    Paula LG; da Costa BE; Poli-de-Figueiredo CE; Antonello IC
    Hypertens Pregnancy; 2008; 27(4):413-20. PubMed ID: 19003642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of progression to a high risk situation in women with gestational hypertension or mild pre-eclampsia at term.
    van der Tuuk K; Koopmans CM; Groen H; Aarnoudse JG; van den Berg PP; van Beek JJ; Copraij FJ; Kleiverda G; Porath M; Rijnders RJ; van der Salm PC; Santema JG; Stigter RH; Mol BW; van Pampus MG;
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):339-46. PubMed ID: 21806572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating between gestational and chronic hypertension; an explorative study.
    Terwisscha van Scheltinga JA; Krabbendam I; Spaanderman ME
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):312-7. PubMed ID: 23237537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
    Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
    Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we predict recurrence of pre-eclampsia or gestational hypertension?
    Brown MA; Mackenzie C; Dunsmuir W; Roberts L; Ikin K; Matthews J; Mangos G; Davis G
    BJOG; 2007 Aug; 114(8):984-93. PubMed ID: 17573736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia.
    Le TM; Nguyen LH; Phan NL; Le DD; Nguyen HVQ; Truong VQ; Cao TN
    Int J Gynaecol Obstet; 2019 Jan; 144(1):21-26. PubMed ID: 30353543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine investigations might be useful in pre-eclampsia, but not in gestational hypertension.
    Bailey DJ; Walton SM
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):144-7. PubMed ID: 15760317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY; Bian XM; Jiang YL; Liu SY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy.
    August P; Helseth G; Cook EF; Sison C
    Am J Obstet Gynecol; 2004 Nov; 191(5):1666-72. PubMed ID: 15547540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure in different gestational trimesters, fetal growth, and the risk of adverse birth outcomes: the generation R study.
    Bakker R; Steegers EA; Hofman A; Jaddoe VW
    Am J Epidemiol; 2011 Oct; 174(7):797-806. PubMed ID: 21859836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
    Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
    Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes for nulliparous women of advanced maternal age in South Australia, 1998-2008.
    Ludford I; Scheil W; Tucker G; Grivell R
    Aust N Z J Obstet Gynaecol; 2012 Jun; 52(3):235-41. PubMed ID: 22553967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension.
    Liro M; Gasowski J; Wydra D; Grodzicki T; Emerich J; Narkiewicz K
    Blood Press; 2009; 18(1-2):36-43. PubMed ID: 19353410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.
    Livingston JR; Payne B; Brown M; Roberts JM; Côté AM; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):870-877. PubMed ID: 25375299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma volume determination in pregnancies complicated by chronic hypertension and intrauterine fetal demise.
    Sibai BM; Abdella TN; Anderson GD; McCubbin JH
    Obstet Gynecol; 1982 Aug; 60(2):174-8. PubMed ID: 7155477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.